TGA issues unapproved peptide warning

Regulator flags concerns over rise in import, supply, compounding and advertising of unapproved peptide products  Pharmacists are being urged to ensure they comply with all regulatory requirements and professional practice standards if they compound or supply unapproved peptide products.  The Therapeutic Goods Administration (TGA) has issued a safety advisory warning of potential safety risks associated with unapproved peptides.   “Under the Therapeutic Goods Act 1989, peptide products are